HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lung surgery for metastatic epithelial tumours.

AbstractINTRODUCTION:
The aim of this study is to evaluate outcomes following the surgical treatment of pulmonary metastases in patients with different types of epithelial cancers, as well as to identify prognostic factors after metastasectomy.
MATERIAL/METHODS:
We retrospectively reviewed data for 61 patients who underwent 76 curative resections of pulmonary metastases from epithelial tumours during 1997-2002 at our department. Potential prognostic factors affecting survival after lung metastasectomy were analysed: disease-free interval (DFI), gender, age, the size and number of metastases, mono- or bilateral tumour, number of operations and the extent of pulmonary resection.
RESULTS:
The median survival was 36 months. Three factors were identified as prognostic for survival after metastasectomy: DFI<24 (p=0.0045), unilateral pulmonary metastases (p=0.0062) and no more than one operation (p=0.0065).
CONCLUSIONS:
We concluded that: i) Resection of epithelial pulmonary metastases may offer a significant survival benefit for selected patients. ii) Good surgical candidates for pulmonary resection are those with a disease-free interval greater than 24 months. iii) The total number of thoracotomies, and metastases confined to one lung are factors defining patients who experience a better outcome after surgery. iv) Lung metastasectomy by conventional surgery is a safe procedure with low perioperative morbidity and mortality rates.
AuthorsWitold Kycler, Anna Kubiak, Piotr Laski, Zefiryn Cybulski, Hanna Perz
JournalPostepy higieny i medycyny doswiadczalnej (Online) (Postepy Hig Med Dosw (Online)) Vol. 69 Pg. 277-84 (Mar 05 2015) ISSN: 1732-2693 [Electronic] Poland
PMID25748618 (Publication Type: Journal Article)
Topics
  • Adult
  • Age Factors
  • Aged
  • Carcinoma (secondary, surgery)
  • Cohort Studies
  • Female
  • Humans
  • Lung Neoplasms (surgery)
  • Male
  • Metastasectomy
  • Middle Aged
  • Prognosis
  • Retrospective Studies
  • Sex Factors
  • Survival Rate
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: